Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Silicon containing doai
Patent
1986-03-27
1987-06-02
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Silicon containing doai
514 79, 514 80, 514 89, 514 92, 514 94, 514 95, 514 99, 514119, 544229, 544337, 546 14, 546 22, 546 23, 548110, 548112, 548119, 548406, 548413, 548414, 548953, 549 4, 549 6, 549214, 549218, 556 19, 558174, A61K 3166, A61K 31675, C07F 932, C07F 965
Patent
active
046704221
ABSTRACT:
Compounds of the formula ##STR1## wherein X is various amino or imino acids and esters are disclosed. These compounds are useful as anti-hypertensive agents due to their angiotensin converting enzyme inhibition activity and depending upon the definition of X may also be useful as analgesics due to their enkephalinase inhibition activity.
REFERENCES:
patent: 4452790 (1984-06-01), Karanewsky et al.
Dejneka Tamara
Karanewsky Donald S.
Davis Stephen B.
E. R. Squibb & Sons Inc.
Levinson Lawrence S.
Raymond Richard L.
LandOfFree
.alpha.-acyloxy phosphonate angiotensin converting enzyme inhibi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .alpha.-acyloxy phosphonate angiotensin converting enzyme inhibi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .alpha.-acyloxy phosphonate angiotensin converting enzyme inhibi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-613653